Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results
| Autor: | Turunç, V., Açıkgöz, S.B., Dheir, H. |
|---|---|
| Zdroj: | In Transplantation Proceedings May 2019 51(4):1070-1073 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect